Objective(s): Pediatric acute lymphoblastic leukemia (pALL) is the most prevalent neoplasm in children. pALL diagnostic process is invasive, and children need to be anesthetized for bone marrow aspiration. Exosomes are nanoparticles that reflect the status of parental cells. Given the elevated levels of exosomes in the peripheral blood of pALL patients, they can be readily extracted from blood plasma. The aim of this study was to compare the reliability of two different techniques of exosome purification in order to select the best method for clinical use in pALL. Methods: Exosomes were isolated from plasma samples using two methods: ultracentrifugation and the ExoQuick exosome isolation (EQ) kit. The performances of these methods were compared based on the nanoparticle tracking analysis (NTA), field emission electron microscopy (FESEM), and immunoblotting assays. Results: NTA results showed that exosome fractions extracted by the EQ kit were more concentrated and homogeneous compared with the ultracentrifugation method. Electron microscopy depicted spherical morphology for the isolated exosomes in both methods; however, the appearance of exosomes enriched by the commercial kit was more intact. Following the immunoblotting assays investigating the exosomal biomarkers, densitometry analysis showed that the exosome populations related to the EQ kit had higher concentrations and extreme purity. Conclusions: The data demonstrated that the commercial kit exhibited superior efficacy in isolating concentrated, intact, and pure exosomes from small quantities of patients' plasma samples when compared to the standard ultracentrifugation method. According to those findings, the ExoQuick exosome segregation kit was preferred to be used in pALL diagnostic investigations.
Bartholomé R. Identification of circulation-derived exosomal microRNA candidates for liquid biopsy in pediatric acute lymphoblastic leukemia: lmu; 2022.
Fu Y, Zhang Y, Khoo BLJMRR. Liquid biopsy technologies for hematological diseases. 2021;41(1):246-74. https://doi.org/10.1002/med.21731
Kato M, Manabe AJPI. Treatment and biology of pediatric acute lymphoblastic leukemia. 2018;60(1):4-12. https://doi.org/10.1111/ped.13457
Ukrainskaya V, Musatova O, Volkov D, Osipova D, Pershin D, Moysenovich A, et al. CAR-tropic extracellular vesicles carry tumor-associated antigens and modulate CAR T cell functionality. 2023;13(1):463. https://doi.org/10.1038/s41598-023-27604-5
Zhu S, Xing C, Li R, Cheng Z, Deng M, Luo Y, et al. Proteomic profiling of plasma exosomes from patients with B-cell acute lymphoblastic leukemia. 2022;12(1):11975. https://doi.org/10.1038/s41598-022-16282-4
Zhang Y, Ge T, Huang M, Qin Y, Liu T, Mu W, et al. Extracellular vesicles expressing CD19 Antigen improve expansion and efficacy of CD19-Targeted CAR-T cells. 2023:49-63. https://doi.org/10.2147/IJN.S390720
Miljkovic-Licina M, Arraud N, Zahra AD, Ropraz P, Matthes TJC. Quantification and phenotypic characterization of extracellular vesicles from patients with acute myeloid and B-cell lymphoblastic leukemia. 2021;14(1):56. https://doi.org/10.3390/cancers14010056
Zhang J, Li S, Li L, Li M, Guo C, Yao J, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. 2015;13(1):17-24. https://doi.org/10.1016/j.gpb.2015.02.001
Chai C, Sui K, Tang J, Yu H, Yang C, Zhang H, et al. BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution. 2023;13(12):3943. https://doi.org/10.7150/thno.83178
Colangelo T, Panelli P, Mazzarelli F, Tamiro F, Melocchi V, De Santis E, et al. Extracellular vesicle microRNAs contribute to Notch signaling pathway in T-cell acute lymphoblastic leukemia. 2022;21(1):226. https://doi.org/10.1186/s12943-022-01698-3
Bæk R, Søndergaard EK, Varming K, Jørgensen MMJJoIM. The impact of various preanalytical treatments on the phenotype of small extracellular vesicles in blood analyzed by protein microarray. 2016;438:11-20. https://doi.org/10.1016/j.jim.2016.08.007
Salvianti F, Gelmini S, Costanza F, Mancini I, Sonnati G, Simi L, et al. The pre-analytical phase of the liquid biopsy. 2020;55:19-29. https://doi.org/10.1016/j.nbt.2019.09.006
Lötvall J, Hill AF, Hochberg F, Buzás EI, Di Vizio D, Gardiner C, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. Taylor & Francis; 2014. p. 26913. https://doi.org/10.3402/jev.v3.26913
Neerukonda SN, Egan NA, Patria J, Assakhi I, Tavlarides-Hontz P, Modla S, et al. Comparison of exosomes purified via ultracentrifugation (UC) and Total Exosome Isolation (TEI) reagent from the serum of Marek's disease virus (MDV)-vaccinated and tumor-bearing chickens. 2019;263:1-9. https://doi.org/10.1016/j.jviromet.2018.10.004
Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. 2013;2(1):20360. https://doi.org/10.3402/jev.v2i0.20360
Krafft C, Wilhelm K, Eremin A, Nestel S, von Bubnoff N, Schultze-Seemann W, et al. A specific spectral signature of serum and plasma-derived extracellular vesicles for cancer screening. 2017;13(3):835-41. https://doi.org/10.1016/j.nano.2016.11.016
Théry C, Amigorena S, Raposo G, Clayton AJCpicb. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. 2006;30(1):3.22. 1-3.. 9. https://doi.org/10.1002/0471143030.cb0322s30
Filipe V, Hawe A, Jiskoot WJPr. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. 2010;27:796-810. https://doi.org/10.1007/s11095-010-0073-2
Azonano W. Reviewing the use of nanoparticle tracking analysis (NTA) for nanomaterial characterization. 2015.
Soares Martins T, Catita J, Martins Rosa I, AB da Cruz e Silva O, Henriques AGJPo. Exosome isolation from distinct biofluids using precipitation and column-based approaches. 2018;13(6):e0198820. https://doi.org/10.1371/journal.pone.0198820
Yuana Y, Böing AN, Grootemaat AE, van der Pol E, Hau CM, Cizmar P, et al. Handling and storage of human body fluids for analysis of extracellular vesicles. 2015;4(1):29260. https://doi.org/10.3402/jev.v4.29260
Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J, et al. Impact of pre‐analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. 2012;10(3):437-46. https://doi.org/10.1111/j.1538-7836.2011.04610.x
Yu L-L, Zhu J, Liu J-X, Jiang F, Ni W-K, Qu L-S, et al. A comparison of traditional and novel methods for the separation of exosomes from human samples. 2018;2018. https://doi.org/10.1155/2018/3634563
Alvarez ML, Khosroheidari M, Ravi RK, DiStefano JKJKi. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. 2012;82(9):1024-32. https://doi.org/10.1038/ki.2012.256
Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PPJBri. Isolation of extracellular vesicles: general methodologies and latest trends. 2018;2018. https://doi.org/10.1155/2018/8545347
Yang D, Zhang W, Zhang H, Zhang F, Chen L, Ma L, et al. Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics. 2020;10(8):3684. https://doi.org/10.7150/thno.41580
Sidhom K, Obi PO, Saleem AJIJoMS. A review of exosomal isolation methods: is size exclusion chromatography the best option? 2020;21(18):6466. https://doi.org/10.3390/ijms21186466
Palviainen M, Saraswat M, Varga Z, Kitka D, Neuvonen M, Puhka M, et al. Extracellular vesicles from human plasma and serum are carriers of extravesicular cargo-Implications for biomarker discovery. 2020;15(8):e0236439. https://doi.org/10.1371/journal.pone.0236439
Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. 2018;7(1):1535750. https://doi.org/10.1080/20013078.2018.1461450
Lobb RJ, Becker M, Wen Wen S, Wong CS, Wiegmans AP, Leimgruber A, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. 2015;4(1):27031. https://doi.org/10.3402/jev.v4.27031
Coughlan C, Bruce KD, Burgy O, Boyd TD, Michel CR, Garcia‐Perez JE, et al. Exosome isolation by ultracentrifugation and precipitation and techniques for downstream analyses. 2020;88(1):e110. https://doi.org/10.1002/cpcb.110
Saffari,N. , Rahgozar,S. and Sahin,F. (2024). Optimizing Exosome Enrichment: A Comparative Study in Pediatric Acute Lymphoblastic Leukemia Patients. Nanomedicine Research Journal, 9(2), 172-179. doi: 10.22034/nmrj.2024.02.006
MLA
Saffari,N. , , Rahgozar,S. , and Sahin,F. . "Optimizing Exosome Enrichment: A Comparative Study in Pediatric Acute Lymphoblastic Leukemia Patients", Nanomedicine Research Journal, 9, 2, 2024, 172-179. doi: 10.22034/nmrj.2024.02.006
HARVARD
Saffari N., Rahgozar S., Sahin F. (2024). 'Optimizing Exosome Enrichment: A Comparative Study in Pediatric Acute Lymphoblastic Leukemia Patients', Nanomedicine Research Journal, 9(2), pp. 172-179. doi: 10.22034/nmrj.2024.02.006
CHICAGO
N. Saffari, S. Rahgozar and F. Sahin, "Optimizing Exosome Enrichment: A Comparative Study in Pediatric Acute Lymphoblastic Leukemia Patients," Nanomedicine Research Journal, 9 2 (2024): 172-179, doi: 10.22034/nmrj.2024.02.006
VANCOUVER
Saffari N., Rahgozar S., Sahin F. Optimizing Exosome Enrichment: A Comparative Study in Pediatric Acute Lymphoblastic Leukemia Patients. Nanomed Res J, 2024; 9(2): 172-179. doi: 10.22034/nmrj.2024.02.006